Background: Healthcare is a special case in several economic markets especially in the United States. It is vital to determine if COVID-19 vaccine production ful lls the conventional economic prediction model to inform policy evolving vaccine productions. To determine potential market characteristics, externalities and pro t maximization conditions for entry and exit in the COVID-19 vaccine market. To establish the factors that play vital role in production decision making for new and or existing pharmaceutical companies producing COVID-19 vaccines. The determination of perfect competition and potential violation assumptions where the government can play a role for social welfare.
Economic Conceptual Model:The economic theory for perfect competition, and profit maximization conditions that must hold to achieve efficient market point is utilized to project possible solutions. The theory serves as a foundation in determining if indeed the existing COVID-19 vaccine production align with perfect competition characteristics and what characteristics a potential pharmaceutical company may consider to enter or exit the existing market. The synthesis of the theory framework helps determine the externalities, potential violations caused by real world vaccine production scenario, and barriers to entry. Synthesis of existing literature helps support the theory assumptions.
Observation and relevance:The government subsidies play a vital role in encouraging new pharmaceutical companies to participate in research and development of COVID-19 vaccines. The current real world scenario has limited demand and supply side heads, introducing uncertainties in production decision making. Vaccine patent, price negotiation constrains, co-pay/ deductibles on vaccine, and information asymmetry may all contribute to externalities. Booster doses and more information on the life cycle of COVID-19 virus can help mitigate the uncertainties of production. Existing corporate giving, government subsidies, and pricing mechanism on vaccines might impose positive and negative externalities depending on the country of distribution. Future studies might evaluate the existing theory from the perspective of imperfect competition.